OneMedNet Corporation Faces Nasdaq Listing Requirements Issue

Minneapolis, Sept. 12, 2024 (GLOBE NEWSWIRE)

Overview

OneMedNet Corporation (Nasdaq: ONMD), a leader in regulatory-grade Real World Data (“RWD”), received a First Notice from Nasdaq indicating non-compliance due to the Company’s failure to timely file its Form 10-Q for the fiscal quarter ended June 30, 2024 with the SEC.

The Company’s expertise in curating RWD, including electronic health records, laboratory results, and medical imaging, has positioned them as a key player in the healthcare industry. However, this recent issue with Nasdaq may have implications for their continued listing on the stock exchange.

Impact on Me

As an investor in OneMedNet Corporation, this news may cause concern about the stability and financial health of the company. The potential delisting from Nasdaq could result in a loss of investment value and liquidity. It is important to closely monitor the situation and consider the best course of action to protect your investment.

Global Impact

The repercussions of OneMedNet’s listing requirements issue extend beyond individual investors to the broader healthcare and technology sectors. The Company’s innovative approach to RWD has contributed to advancements in research and patient care, making their compliance status a topic of interest for industry stakeholders worldwide. Any changes in the company’s standing with Nasdaq could impact partnerships, funding, and overall progress in healthcare technology.

Conclusion

OneMedNet Corporation’s recent notice from Nasdaq is a reminder of the importance of regulatory compliance and transparent financial reporting in the business world. As the Company navigates this challenge, stakeholders must stay informed and consider the potential implications for their investments and the industry as a whole.